| scholarly article | Q13442814 |
| P356 | DOI | 10.1128/JVI.00689-06 |
| P8608 | Fatcat ID | release_i4in6pvlojgq5koafkt444ttzi |
| P932 | PMC publication ID | 1563785 |
| P698 | PubMed publication ID | 16873253 |
| P50 | author | Subhash Verma | Q57951657 |
| Erle S Robertson | Q88590600 | ||
| P2093 | author name string | Ke Lan | |
| Qiliang Cai | |||
| Huaxin Si | |||
| Doug Lin | |||
| P2860 | cites work | Physical and functional interactions between STAT3 and Kaposi's sarcoma-associated herpesvirus-encoded LANA | Q24299259 |
| General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia | Q24315006 | ||
| Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 | Q24316075 | ||
| Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus | Q24561400 | ||
| The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen | Q24672438 | ||
| HIF1A gene transcription is dependent on a core promoter sequence encompassing activating and inhibiting sequences located upstream from the transcription initiation site and cis elements located within the 5'UTR | Q28140700 | ||
| The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages | Q28143066 | ||
| HIF-1 and human disease: one highly involved factor | Q28144179 | ||
| Oncogenic forms of NOTCH1 lacking either the primary binding site for RBP-Jkappa or nuclear localization sequences retain the ability to associate with RBP-Jkappa and activate transcription | Q28235557 | ||
| Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions | Q28251400 | ||
| Hypoxia--a key regulatory factor in tumour growth | Q29547318 | ||
| Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome | Q30668836 | ||
| A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus | Q33559699 | ||
| Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway | Q33737793 | ||
| Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus | Q33815257 | ||
| DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus | Q33853499 | ||
| p53 inhibition by the LANA protein of KSHV protects against cell death | Q33885642 | ||
| Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) binds ATF4/CREB2 and inhibits its transcriptional activation activity | Q33922095 | ||
| Regulation and autoregulation of the promoter for the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus | Q34292265 | ||
| Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha | Q34346992 | ||
| The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells | Q34511161 | ||
| Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains hypoxia response elements: relevance to lytic induction by hypoxia | Q35019982 | ||
| Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma | Q35131811 | ||
| The hypoxia-inducible factor-1 DNA recognition site is cAMP-responsive | Q38348904 | ||
| Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells | Q39596534 | ||
| Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1. | Q39992257 | ||
| STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells | Q40416582 | ||
| Role of CBP in regulating HIF-1-mediated activation of transcription. | Q40477750 | ||
| Transcriptional coactivation of c-Jun by the KSHV-encoded LANA. | Q40635358 | ||
| Identification of a tightly regulated hypoxia-response element in the promoter of human plasminogen activator inhibitor-1. | Q40747151 | ||
| Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus | Q40807418 | ||
| The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus transactivates the telomerase reverse transcriptase promoter | Q40811288 | ||
| Auto-activation of the rta gene of human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus | Q40841209 | ||
| Oxygen sensing and molecular adaptation to hypoxia | Q41075727 | ||
| Expression of erythropoietin and erythropoietin receptor in non-small cell lung carcinomas. | Q53781648 | ||
| Tumor hypoxia in pelvic recurrences of cervical cancer. | Q54128665 | ||
| Targeting gene expression to hypoxic tumor cells | Q57377984 | ||
| Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1 | Q63565692 | ||
| Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein | Q77760836 | ||
| Influence of the hypoxic subvolume on the survival of patients with head and neck cancer | Q77936400 | ||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoxia | Q105688 |
| P304 | page(s) | 7965-7975 | |
| P577 | publication date | 2006-08-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions | |
| P478 | volume | 80 |
| Q40106826 | A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia |
| Q34179693 | A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening. |
| Q91757226 | A role of hypoxia-inducible factor 1 alpha in Murine Gammaherpesvirus 68 (MHV68) lytic replication and reactivation from latency |
| Q28535343 | A unique SUMO-2-interacting motif within LANA is essential for KSHV latency |
| Q26743368 | Activation of DNA Damage Response Induced by the Kaposi's Sarcoma-Associated Herpes Virus |
| Q28750291 | Angiogenesis, Kaposi's Sarcoma and Kaposi's Sarcoma-Associated Herpesvirus |
| Q36782271 | CD147 and downstream ADAMTSs promote the tumorigenicity of Kaposi's sarcoma-associated herpesvirus infected endothelial cells. |
| Q26749612 | Cell Cycle Regulatory Functions of the KSHV Oncoprotein LANA |
| Q28728172 | Characterization of omental immune aggregates during establishment of a latent gammaherpesvirus infection |
| Q37204595 | Characterization of the interaction between latency-associated nuclear antigen and glycogen synthase kinase 3beta |
| Q35237492 | Chromatinization of the KSHV Genome During the KSHV Life Cycle |
| Q39646942 | Development of an oncolytic herpes simplex virus using a tumor-specific HIF-responsive promoter |
| Q39152964 | Effects of the NEDD8-activating enzyme inhibitor MLN4924 on lytic reactivation of Kaposi's sarcoma-associated herpesvirus |
| Q36167973 | Fine-Tuning of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle in Neighboring Cells through the RTA-JAG1-Notch Pathway. |
| Q40174372 | HIV-associated Kaposi sarcoma and related diseases. |
| Q92255602 | Herpesviruses and the Unfolded Protein Response |
| Q39668742 | Hypoxia induces the gene expression and extracellular transmission of persistent lymphocytic choriomeningitis virus |
| Q37009862 | Hypoxia inducible factor (HIF) function in innate immunity and infection |
| Q27001095 | Hypoxia-inducible factor 1 and its role in viral carcinogenesis |
| Q42366342 | Hypoxia-inducible factor-1 alpha as a therapeutic target for primary effusion lymphoma. |
| Q33842381 | Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus's natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter. |
| Q35034278 | IRF-4-mediated CIITA transcription is blocked by KSHV encoded LANA to inhibit MHC II presentation |
| Q35720026 | Identification of Caspase Cleavage Sites in KSHV Latency-Associated Nuclear Antigen and Their Effects on Caspase-Related Host Defense Responses |
| Q91918273 | Identification of viral SIM-SUMO2-interaction inhibitors for treating primary effusion lymphoma |
| Q36433852 | Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1. |
| Q33743831 | Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ. |
| Q54597465 | Interaction of the human cytomegalovirus particle with the host cell induces hypoxia-inducible factor 1 alpha. |
| Q37671058 | Interactome mapping: using protein microarray technology to reconstruct diverse protein networks |
| Q37586121 | Interdependence of hypoxic and innate immune responses |
| Q34615002 | Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system |
| Q26766437 | KSHV Genome Replication and Maintenance |
| Q49363063 | KSHV LANA upregulates the expression of epidermal growth factor like domain 7 to promote angiogenesis. |
| Q28080937 | KSHV reactivation and novel implications of protein isomerization on lytic switch control |
| Q35810446 | KSHV-Encoded MicroRNAs: Lessons for Viral Cancer Pathogenesis and Emerging Concepts |
| Q26742030 | KSHV-Mediated Angiogenesis in Tumor Progression |
| Q93074235 | KSHV-encoded LANA protects the cellular replication machinery from hypoxia induced degradation |
| Q39819343 | Kaposi sarcoma-associated herpes virus (KSHV) G protein-coupled receptor (vGPCR) activates the ORF50 lytic switch promoter: a potential positive feedback loop for sustained ORF50 gene expression |
| Q28472867 | Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion |
| Q34186981 | Kaposi's sarcoma herpesvirus upregulates Aurora A expression to promote p53 phosphorylation and ubiquitylation |
| Q39665994 | Kaposi's sarcoma-associated herpesvirus inhibits interleukin-4-mediated STAT6 phosphorylation to regulate apoptosis and maintain latency |
| Q91397053 | Kaposi's sarcoma-associated herpesvirus is cell-intrinsically controlled in latency in microgravity |
| Q35665756 | Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induction by hypoxia and hypoxia-inducible factors |
| Q38859450 | Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin |
| Q33744019 | Kaposi's sarcoma-associated herpesvirus-encoded LANA interacts with host KAP1 to facilitate establishment of viral latency |
| Q35010647 | Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation |
| Q53781024 | Metabolic reprogramming of Kaposi's sarcoma associated herpes virus infected B-cells in hypoxia. |
| Q90319823 | Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis |
| Q35124404 | Molecular Biology of Kaposi's Sarcoma-associated Herpesvirus and Related Oncogenesis |
| Q35014918 | Molecular biology of KSHV lytic reactivation |
| Q35571588 | Next-Generation Sequencing Analysis Reveals Differential Expression Profiles of MiRNA-mRNA Target Pairs in KSHV-Infected Cells |
| Q36252859 | Nuclear Localization and Cleavage of STAT6 Is Induced by Kaposi's Sarcoma-Associated Herpesvirus for Viral Latency |
| Q40094006 | ORF73-null murine gammaherpesvirus 68 reveals roles for mLANA and p53 in virus replication |
| Q90660427 | Oncogenic human herpesvirus hijacks proline metabolism for tumorigenesis |
| Q42166459 | Oxidative Stress Induces Reactivation of Kaposi's Sarcoma-Associated Herpesvirus and Death of Primary Effusion Lymphoma Cells |
| Q38121335 | Oxygen tension level and human viral infections. |
| Q34456086 | Phosphorylation of the chromatin binding domain of KSHV LANA |
| Q33282107 | Protein complexes associated with the Kaposi's sarcoma-associated herpesvirus-encoded LANA. |
| Q36238539 | RNA Sequencing Reveals that Kaposi Sarcoma-Associated Herpesvirus Infection Mimics Hypoxia Gene Expression Signature. |
| Q28476740 | Rapamycin blocks production of KSHV/HHV8: insights into the anti-tumor activity of an immunosuppressant drug |
| Q39284842 | Reactivation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus: An Update |
| Q99591124 | Regulation of KSHV Latency and Lytic Reactivation |
| Q39581099 | Role of the cellular transcription factor YY1 in the latent-lytic switch of Kaposi's sarcoma-associated herpesvirus |
| Q61811187 | Systemically Administered Reovirus-Induced Downregulation of Hypoxia Inducible Factor-1α in Subcutaneous Tumors |
| Q34286796 | Targeted genes and interacting proteins of hypoxia inducible factor-1. |
| Q92689673 | The Kaposi's Sarcoma-Associated Herpesvirus ORF34 Protein Interacts and Stabilizes HIF-2α via Binding to the HIF-2α bHLH and PAS Domains |
| Q39230427 | The Kaposi's sarcoma-associated herpesvirus ORF34 protein binds to HIF-1α and causes its degradation via the proteasome pathway |
| Q35140238 | The internal Kaposi's sarcoma-associated herpesvirus LANA regions exert a critical role on episome persistence |
| Q37380228 | The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency |
| Q39329214 | The role of metabolic reprogramming in γ-herpesvirus-associated oncogenesis. |
| Q35077558 | The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection |
| Q40020501 | Up-regulation of Murid herpesvirus 4 ORF50 by hypoxia: possible implication for virus reactivation from latency. |
| Q34168712 | Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma |
| Q34013770 | Upregulation of cellular Bcl-2 by the KSHV encoded RTA promotes virion production |
| Q66679091 | Viral hijacking of cellular metabolism |
| Q39858771 | X-box binding protein 1 contributes to induction of the Kaposi's sarcoma-associated herpesvirus lytic cycle under hypoxic conditions |
Search more.